About UMC

Signal Review Panel

For over fifteen years the UMC has been fortunate to have the assistance of volunteer consultants as 'signal reviewers'. These clinical experts review the results of the regular computerised screenings of ADR reports submitted to the WHO Programme. The results of their work, consisting of a summary of available evidence, are circulated to national pharmacovigilance centres periodically in the 'SIGNAL' document.

For information on the reviewers, click on their names below (full information on all reviewers not available at present):

Dr Ariel E Arias, Canada
Dr Joanne Barnes, New Zealand
Dr Anna-Lena Berggren, Sweden
Prof Gunnar Boman, Sweden
Dr Ian Boyd, Australia
Prof Alfonso Carvajal, Spain
Dr Raquel Herrera Comoglio, Argentina
Dr Anita Conforti, Italy
Dr Ana Maria Corrêa Nunes, Portugal
Prof Dr Andrew Czeizel, Hungary
Prof Richard Day, Australia
Prof Peter de Smet, Netherlands
Dr P Murali Doraiswamy, USA
Prof Edzard Ernst, United Kingdom
Dr Rick Fraunfelder, USA
Ms Birgitta Grundmark, Sweden
Dr Pär Hallberg, Sweden
Dr Kenneth Hartigan-Go, Philippines
Dr Staffan Hägg, Sweden
Prof Peter Jacobs, South Africa
Dr Sylvia Kardaun, Netherlands
Ms Anne Kiuru, Sweden
Prof Milan Kriška, Slovakia
Dr Nilima Kshirsagar, India
Prof Michael Langman, United Kingdom

Prof P O Lundberg, Sweden
Dr Jens Lundgren, Denmark
Dr M Laurie Mashford, Australia
Dr John McEwen, Australia
Dr Ronald H B Meyboom, Netherlands
Dr Ed Napke, Canada
Prof Tamás L Paál, Hungary
Dr Martin Pfeiffer, Germany
Dr Robert Pless, Canada
Dr Emilio J Sanz, Spain
Dr Ruth Savage, New Zealand
Dr Saad Shakir, United Kingdom
Dr Debbie Shaw, United Kingdom
Mr Ivan Stockley, United Kingdom
Dr Michael Tatley, New Zealand
Dr Mary Teeling, Ireland
Dr Ingrid Trolin, Sweden
Prof Kiichiro Tsutani, Japan
Prof Giampaolo Velo, Italy
Dr Anthony Wong, Brazil
Dr Qun-Ying Yue, Sweden

Signal Review Panel page last updated 15 May 2013